<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01893814</url>
  </required_header>
  <id_info>
    <org_study_id>PAB/029911</org_study_id>
    <nct_id>NCT01893814</nct_id>
  </id_info>
  <brief_title>Benefit and Tolerability of a Probiotic Product in Infants With Abdominal Discomfort</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Probi AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Probi AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To demonstrate benefit and tolerability of a probiotic product in infants with abdominal
      discomfort.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Poor recruitment
  </why_stopped>
  <start_date>April 2013</start_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of abdominal discomfort as assessed by comparison of crying time</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Abdominal Discomfort</condition>
  <arm_group>
    <arm_group_label>Probiotics</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotics</intervention_name>
    <arm_group_label>Probiotics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female singleton

          -  ≥ 2 weeks and ≤ 12 weeks of age

          -  Exclusively breastfed at screening

          -  Abdominal discomfort (infant colic) in the week prior to enrollment, according to the
             statement of the parent(s) and/or guardian(s)

          -  Episodes of fussy crying that lasted at least 3 hours a day for at least 3 days in the
             7 days prior to enrollment, according to the statement of the parent(s) and/or
             guardian(s)

          -  Voluntary, written informed consent of the parent(s) and/or guardian(s) to participate
             in the study

          -  Born at full term (37-42 after last menstruation period)

          -  Birth weight: 2500 - 4500 g

          -  Weight-for-age ≥ 3th and ≤ 97th percentile according to WHO growth tables / charts

          -  Apparently healthy at birth (Apgar ≥ 8) and at screening visit

          -  No major complications during pregnancy or at birth

          -  Mother 19-45 years of age at childbirth

          -  Ability of parent(s) and/or guardian(s) to attend visits, interviews and willingness
             to fill out questionnaires

        Exclusion Criteria:

          -  Intolerance to investigational product/its ingredients

          -  Severe medical condition or illness, congenital abnormality

          -  Gastrointestinal disorders (e.g. reflux esophagitis)

          -  Intake of probiotics and/or antibiotics in the week preceding recruitment and during
             the study

          -  Formula feeding at screening/randomisation

          -  Allergy or atopic disease (family history)

          -  Participation in another study

          -  Mother's health condition that may interfere with her ability to take care of her
             infant

          -  Mother affected by hepatitis B, HIV or Guillain-Barré Syndrome

          -  Use of antibiotics by the mother in the week
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>12 Weeks</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Charité Virchow Hospital</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2013</study_first_submitted>
  <study_first_submitted_qc>July 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 9, 2013</study_first_posted>
  <last_update_submitted>September 21, 2016</last_update_submitted>
  <last_update_submitted_qc>September 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

